These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36116761)

  • 1. From the original SARS-CoV-2 strain to the Omicron variant: Predictors of COVID-19 in ambulatory symptomatic children.
    Cohen R; Rybak A; Ouldali N; Angoulvant F; Béchet S; Gajdos V; Hau I; Sellam A; El Aouane El Ghomari I; Elmerich F; Batard C; Auvrignon A; Grimprel E; Favier M; Jung C; Levy C
    Infect Dis Now; 2022 Nov; 52(8):432-440. PubMed ID: 36116761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
    Smith H; Mahon A; Moss A; Rao S
    J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).
    Beraud G; Bouetard L; Civljak R; Michon J; Tulek N; Lejeune S; Millot R; Garchet-Beaudron A; Lefebvre M; Velikov P; Festou B; Abgrall S; Lizatovic IK; Baldolli A; Esmer H; Blanchi S; Froidevaux G; Kapincheva N; Faucher JF; Duvnjak M; Afşar E; Švitek L; Yarimoglu S; Yarimoglu R; Janssen C; Epaulard O;
    Clin Microbiol Infect; 2023 May; 29(5):642-650. PubMed ID: 36587737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada.
    Sumner MW; Xie J; Zemek R; Winston K; Freire G; Burstein B; Kam A; Emsley J; Gravel J; Porter R; Sabhaney V; Mater A; Salvadori MI; Berthelot S; Beer D; Poonai N; Moffatt A; Wright B; Freedman SB;
    JAMA Netw Open; 2023 Mar; 6(3):e232328. PubMed ID: 36892839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.
    Westerhof I; de Hoog M; Ieven M; Lammens C; van Beek J; Rozhnova G; Eggink D; Euser S; Wildenbeest J; Duijts L; van Houten M; Goossens H; Giaquinto C; Bruijning-Verhagen P
    Int J Infect Dis; 2023 Mar; 128():140-147. PubMed ID: 36566773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years - Mississippi, September-November 2020.
    Hobbs CV; Martin LM; Kim SS; Kirmse BM; Haynie L; McGraw S; Byers P; Taylor KG; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1925-1929. PubMed ID: 33332298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
    JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Admission to the Pediatric Intensive Care Unit for SARS-CoV-2 Delta and Omicron Infections.
    Recher M; Leteurtre S; Javouhey E; Morin L; Baudin F; Rambaud J; Mortamet G; Hubert H; Angoulvant F; Levy M;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):189-197. PubMed ID: 36786499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
    Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of SARS-CoV-2 testing in children during a low prevalence period (VIGIL study 1).
    Eskander E; Jung C; Levy C; Béchet S; Blot N; Gorde S; le Stradic C; Come M; Touitou R; Cohen R
    Infect Dis Now; 2021 Sep; 51(6):552-555. PubMed ID: 34271254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.